Incyte Corp $ 92.98 -1.34 (-1.42%)
On watch
Volume:
1,571,317
Avg Vol (1m):
1,389,297
Market Cap $:
20.33 Bil
Enterprise Value $:
18.81 Bil
P/E (TTM):
0.00
P/B:
8.62
Financial Strength | 8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 25.74 | ||
| Equity-to-Asset | 0.73 | ||
| Debt-to-Equity | 0.03 | ||
| Debt-to-EBITDA | -0.92 | ||
| Piotroski F-Score | 2 | ||
| Altman Z-Score | 14.64 | ||
| Beneish M-Score | -2.49 | ||
| WACC vs ROIC | |||
Profitability Rank | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -7.74 | ||
| Net Margin % | -8 | ||
| ROE % | -8.27 | ||
| ROA % | -6.14 | ||
| ROC (Joel Greenblatt) % | -29.03 | ||
| 3-Year Revenue Growth Rate | 20.3 | ||
| 3-Year EBITDA Growth Rate | 33.3 | ||
| 3-Year EPS without NRI Growth Rate | 56 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 8.62 | ||
| PS Ratio | 8.5 | ||
| EV-to-EBIT | -156.22 | ||
| EV-to-EBITDA | -278.7 | ||
| EV-to-Revenue | 7.87 | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 3.7 | ||
| Days Inventory | 33.02 | ||
| Days Sales Outstanding | 64.25 | ||
| Days Payable | 269.94 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.6 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 10.11 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 6.59 | ||
| Price-to-Median-PS-Value | 0.54 | ||
| Earnings Yield (Greenblatt) % | -0.63 |